Risk Perception Scale of Disease Aggravation for older patients with non‐communicable diseases: Instrument development and cross‐sectional validation study

克朗巴赫阿尔法 组内相关 比例(比率) 探索性因素分析 验证性因素分析 利克特量表 横断面研究 临床心理学 表面有效性 心理学 判别效度 非传染性疾病 收敛有效性 医学 心理测量学 疾病 统计 发展心理学 结构方程建模 病理 内部一致性 物理 量子力学 数学
作者
Jizhe Wang,Ying Wang,Na Na,Mengqi Liu,Lulu Xiu,Xiaohong Lü,Xiuli Zhu
出处
期刊:Journal of Advanced Nursing [Wiley]
卷期号:80 (1): 287-300 被引量:2
标识
DOI:10.1111/jan.15774
摘要

The present study aimed to develop the Risk Perception Scale of Disease Aggravation for older patients with non-communicable diseases and evaluate its psychometric properties.Instrument development and cross-sectional validation study were conducted.This study contained four phases. In phase I, a systematic literature review was conducted to identify the conception of disease aggravation and risk perception. In phase II, a draft scale was formulated from face-to-face semi-structured in-depth interviews by Colaizzi's seven-step qualitative analysis method and group discussions among the researchers. In phase III, domains and items of the scale were revised in accordance with the suggestions from Delphi consultation and patient feedback. In phase IV, psychometric properties were evaluated.Exploratory and confirmatory factor analyses determined four structural factors. Convergent and discriminant validities were acceptable because the average variance extracted coefficients ranged from .622 to .725, and the square roots of the average variance extracted coefficients for the four domains were larger than those of bivariate correlations between domains. The scale also exhibited excellent internal consistency and test-retest reliability (Cronbach's alpha coefficient = .973, intraclass correlation coefficient = .840).Risk Perception Scale of Disease Aggravation is a new instrument that measures the risk perception of disease aggravation for older patients with non-communicable diseases, including possible reason, serious outcome, behaviour control and affection experience. The scale contains 40 items that are scored on a 5-point Likert scale, and it has acceptable validity and reliability.The scale is applied to identify different levels of risk perception of disease aggravation for older patients with non-communicable diseases. Clinical nurses can provide targeted interventions to improve older patients' risk perception of disease aggravation based on levels of risk perception during hospitalization and the period before discharge.Experts provided suggestions for revising the scale dimensions and items. Older patients participated in the scale revision process to improve the wording of the scale.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小青椒应助nihao采纳,获得30
刚刚
xingyi完成签到,获得积分10
1秒前
活力的念蕾完成签到,获得积分10
1秒前
yygz0703完成签到 ,获得积分10
2秒前
3秒前
lxz发布了新的文献求助10
3秒前
xxd发布了新的文献求助10
4秒前
甜蜜的曼梅完成签到,获得积分10
4秒前
欣慰的书本完成签到,获得积分10
4秒前
4秒前
量子星尘发布了新的文献求助10
5秒前
归尘发布了新的文献求助10
7秒前
自觉从筠发布了新的文献求助10
8秒前
高高保温杯完成签到,获得积分10
9秒前
今后应助xxd采纳,获得10
10秒前
小白完成签到,获得积分10
10秒前
不开心我的完成签到,获得积分20
11秒前
11秒前
酵母君完成签到,获得积分10
11秒前
中小药完成签到,获得积分10
12秒前
13秒前
16秒前
16秒前
CodeCraft应助酵母君采纳,获得10
17秒前
阳光翩跹完成签到 ,获得积分10
17秒前
17秒前
李li完成签到,获得积分10
19秒前
19秒前
Aypnia发布了新的文献求助10
20秒前
20秒前
21秒前
北过完成签到,获得积分10
22秒前
元谷雪发布了新的文献求助10
22秒前
23秒前
buno应助can采纳,获得10
24秒前
25秒前
nakl完成签到,获得积分10
25秒前
26秒前
26秒前
04liqian发布了新的文献求助10
26秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
人脑智能与人工智能 1000
King Tyrant 720
Silicon in Organic, Organometallic, and Polymer Chemistry 500
Principles of Plasma Discharges and Materials Processing, 3rd Edition 400
Pharmacology for Chemists: Drug Discovery in Context 400
El poder y la palabra: prensa y poder político en las dictaduras : el régimen de Franco ante la prensa y el periodismo 400
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5604302
求助须知:如何正确求助?哪些是违规求助? 4689045
关于积分的说明 14857600
捐赠科研通 4697314
什么是DOI,文献DOI怎么找? 2541233
邀请新用户注册赠送积分活动 1507355
关于科研通互助平台的介绍 1471867